Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline <i>MSH6</i> Variant: A Case Report.
- DOI
- 10.1002/ccr3.73444
- Published
- 2026-08-31
- Container
- Clin Case Rep
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ccr3.73444,
title = {Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline \<i\>MSH6\</i\> Variant: A Case Report.},
author = {Yokozawa T and Nakagawa S and Suzuki Y and Tokinaga-Uchiyama A and Konnai K and Narimatsu H and Hiroshima Y and Saji H.},
year = {2026},
journal = {Clin Case Rep},
doi = {10.1002/ccr3.73444},
url = {https://doi.org/10.1002/ccr3.73444}
}RIS
TY - JOUR TI - Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline <i>MSH6</i> Variant: A Case Report. AU - Yokozawa T AU - Nakagawa S AU - Suzuki Y AU - Tokinaga-Uchiyama A AU - Konnai K AU - Narimatsu H AU - Hiroshima Y AU - Saji H. PY - 2026 JO - Clin Case Rep DO - 10.1002/ccr3.73444 UR - https://doi.org/10.1002/ccr3.73444 ER -
APA
T, Y., S, N., Y, S., A, T., K, K., H, N., Y, H., & H., S. (2026). Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline <i>MSH6</i> Variant: A Case Report.. Clin Case Rep. https://doi.org/10.1002/ccr3.73444
Source records
- europe-pmc · retrieved 2026-09-26T02:01:41.205Z
- doaj · retrieved 2026-09-26T02:01:41.224Z